BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27440383)

  • 1. peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas.
    Martínez-Sáez E; Peg V; Ortega-Aznar A; Martínez-Ricarte F; Camacho J; Hernández-Losa J; Ferreres Piñas JC; Ramón Y Cajal S
    Cancer Med; 2016 Sep; 5(9):2501-12. PubMed ID: 27440383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
    Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
    Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
    Fan W; Wang W; Mao X; Chu S; Feng J; Xiao D; Zhou J; Fan S
    J Neurooncol; 2017 Feb; 131(3):485-493. PubMed ID: 27900644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets.
    Ramon Y Cajal S; De Mattos-Arruda L; Sonenberg N; Cortes J; Peg V
    Clin Transl Oncol; 2014 Nov; 16(11):937-41. PubMed ID: 25060567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.
    Ferrandiz-Pulido C; Masferrer E; Toll A; Hernandez-Losa J; Mojal S; Pujol RM; Ramon y Cajal S; de Torres I; Garcia-Patos V
    J Urol; 2013 Dec; 190(6):2288-95. PubMed ID: 23764082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
    Varughese RK; Skjulsvik AJ; Torp SH
    Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
    Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
    Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
    Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
    APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
    Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
    Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
    Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
    Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
    Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
    Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.
    Torp SH
    Clin Neuropathol; 2002; 21(6):252-7. PubMed ID: 12489673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
    Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
    J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance.
    Sato S; Sato Y; Hatakeyama K; Marutsuka K; Yamashita A; Takeshima H; Asada Y
    Histol Histopathol; 2011 Apr; 26(4):497-504. PubMed ID: 21360443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.